Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.

Zi-Jun Xu,Ye Jin,Xin-Long Zhang,Pei-Hui Xia,Xiang-Mei Wen,Ji-Chun Ma,Jiang Lin,Jun Qian

Cancer medicine（2022）

引用 2|浏览7

暂无评分

摘要

Our study demonstrated CD300s as potential prognostic biomarker and an ideal immunotherapy target in AML, which warrants future functional and clinical studies.

查看译文

关键词

CD300s ,immune evasion,leukemia,pan-cancer,prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要